Biogen Inc. (IDP.F)
Develops and sells medicines for neurological diseases, MS, cancer, and other serious conditions.
186.94+0.06%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+70.9%
The outlook
Biogen is trading near its 52-week highs, well above both its 50- and 200-day moving averages, signaling an uptrend in place. Analyst sentiment leans bullish, though the stock's valuation at a P/E of 22.9 reflects current market optimism. Today's activity shows minimal movement.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range97% of the way from its 52-week low to high
Market cap
$27.60B
52-wk high
189.62
52-wk low
109.00
50-day avg
173.33
200-day avg
157.45
Trailing P/E
22.9